[1] |
Naqvi IH, Mahmood K, Naeem M, et al. The heart matters when the liver shatters! Cirrhotic cardiomyopathy: frequency, comparison, and correlation with severity of disease[J]. Prz Gastroenterol, 2016,11(4):247-256.
|
[2] |
Torregrosa M, Aguadé S, Dos L, et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation[J]. J Hepatol, 2005,42(1):68-74.
|
[3] |
Jake ST, Beaudry R, Haykowsky MJ, et al. Isometric handgrip echocardiography: a noninvasive stress test to assess left ventricular diastolic function[J]. Clin Cardiol, 2017,40(12):1247-1255.
|
[4] |
中华医学会超声医学分会超声心动图学组. 负荷超声心动图规范化操作指南[J]. 中国医学影像技术, 2017,33(4):632-638.
|
[5] |
Yoon K T, Liu H, Lee SS. Cirrhotic Cardiomyopathy[J]. Curr Gastroenterol Rep, 2020,22(9):45.
|
[6] |
Rudzinski W, Waller AH, Prasad A, et al. New index for assessing the chronotropic response in patients with end-stage liver disease who are undergoing dobutamine stress echocardiography[J]. Liver Transpl, 2012,18(3):355-360.
|
[7] |
de Lima-Filho NN, Figueiredo MS, Vicari P, et al. Exercise-induced abnormal increase of systolic pulmonary artery pressure in adult patients with sickle cell anemia: an exercise stress echocardiography study[J]. Echocardiography, 2016,33(12):1880-1890.
|
[8] |
Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy[J]. J Cardiol, 1995,26(6):357.
|
[9] |
Lakoumentas JA, Panou FK, Kotseroglou VK, et al. The Tei index of myocardial performance: applications in cardiology[J]. Hellenic J Cardiol, 2005,46(1):52.
|
[10] |
Moller S, Lee SS. Cirrhotic cardiomyopathy[J]. J Hepatol, 2018,69(4):958-960.
|
[11] |
Fukui H. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia[J]. World J Hepatol, 2015,7(3):425-442.
|
[12] |
Gregolin CS, Do NM, Borges DSS, et al. Myocardial dysfunction in cirrhotic cardiomyopathy is associated with alterations of phospholamban phosphorylation and IL-6 levels[J]. Arch Med Res, 2021,52(3):284-293.
|
[13] |
Fede G, Privitera G, Tomaselli T, et al. Cardiovascular dysfunction in patients with liver cirrhosis[J]. Ann Gastroenterol, 2015,28(1):31-40.
|
[14] |
Barbosa M. Cirrhotic cardiomyopathy: Isn’t stress evaluation always required for the diagnosis?[J]. World J Hepatol, 2016,8(3):200.
|
[15] |
Kim MY, Baik SK, Won CS, et al. Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis[J]. Korean J Hepatol, 2010,16(4):376-382.
|
[16] |
Wong F, Girgrah N, Graba J, et al. The cardiac response to exercise in cirrhosis[J]. Gut, 2001,49(2):268-275.
|
[17] |
Hammami R, Boudabbous M, Jdidi J, et al. Cirrhotic cardiomyopathy: is there any correlation between the stage of cardiac impairment and the severity of liver disease?[J]. Libyan J Med, 2017,12(1):1283162.
|
[18] |
Ren J, Wold LE. Mechanisms of alcoholic heart disease[J]. Ther Adv Cardiovasc Dis, 2008,2(6):497-506.
|
[19] |
Jing L, Jin CM, Li SS, et al. Chronic alcohol intake-induced oxidative stress and apoptosis: role of CYP2E1 and calpain-1 in alcoholic cardiomyopathy[J]. Mol Cell Biochem, 2012,359(1-2):283-292.
|
[20] |
Guo R, Hu N, Kandadi MR, et al. Facilitated ethanol metabolism promotes cardiomyocyte contractile dysfunction through autophagy in murine hearts[J]. Autophagy, 2012,8(4):593-608.
|